Procedure
ALND
ALND is a medical procedure with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Active, not recruiting1
Terminated1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
active_not_recruiting133%
terminated133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
terminatednot_applicable
Preventing Lymphedema in Axillary Lymph Node Dissection
NCT03428581
active_not_recruiting
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
NCT07283718
recruitingnot_applicable
Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy
NCT05241119
Clinical Trials (3)
Showing 3 of 3 trials
NCT03428581Not Applicable
Preventing Lymphedema in Axillary Lymph Node Dissection
NCT07283718
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
NCT05241119Not Applicable
Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3